Statistics for Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
Total visits
| views | |
|---|---|
| Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study | 2 |
Total visits per month
| views | |
|---|---|
| mayo 2024 | 0 |
| junio 2024 | 0 |
| julio 2024 | 0 |
| agosto 2024 | 2 |
| septiembre 2024 | 0 |
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
File Visits
| views | |
|---|---|
| 25_2022_Lataillade_Safety and efficacy of the HIV-1 attachment inhibitor.pdf | 4 |